Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 10/20 | 0.58 |
| ▸ | CTNNB1 | P35222 | 10/20 | 0.58 |
| ▸ | MGLL | Q99685 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.48 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.48 |
| ▸ | FABP2 | P12104 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7813329 | 0.90 | BCL9 (0.56) | BCL9CTNNB1PPARAHSD11B1PARP10 | |
| SCHEMBL7810100 | 0.90 | BCL9 (0.56) | BCL9CTNNB1PPARAKMT2AHSD11B1 | |
| SCHEMBL7814025 | 0.90 | HSD11B1 (0.63) | BCL9CTNNB1PPARAHSD11B1PARP10 | |
| SCHEMBL7814100 | 0.90 | BCL9 (0.56) | BCL9CTNNB1PPARAMEN1KMT2A | |
| SCHEMBL7817510 | 0.88 | BCL9 (0.57) | BCL9CTNNB1PPARAHSD11B1PARP10 | |
| SCHEMBL7811629 | 0.88 | BCL9 (0.54) | BCL9CTNNB1PPARAHSD11B1PARP10 | |
| SCHEMBL7814050 | 0.87 | MEN1 (0.52) | BCL9CTNNB1MGLLPPARAMEN1 | |
| SCHEMBL7817468 | 0.87 | PPARA (0.57) | MGLLPPARAMEN1KMT2AHSD11B1 | |
| SCHEMBL7817728 | 0.84 | BCL9 (0.55) | BCL9CTNNB1PPARAHSD11B1PARP10 | |
| SCHEMBL7811776 | 0.84 | BCL9 (0.54) | BCL9CTNNB1PPARAHSD11B1PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0607536-B1 | Arylamide derivatives | SS PHARMACEUTICAL CO (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |